Personal tools

Coexpression cluster:C145: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|gostat_on_coexpression_clusters=GO:0005184!neuropeptide hormone activity!0.0115249039428662!2922;5368
|gostat_on_coexpression_clusters=GO:0005184!neuropeptide hormone activity!0.0115249039428662!2922;5368
|id=C145
|id=C145
|ontology_enrichment_celltype=
|ontology_enrichment_disease=DOID:3095!6.85e-09!22;DOID:2994!6.85e-09!22;DOID:162!5.19e-07!235;DOID:0050687!8.04e-07!143
|ontology_enrichment_uberon=UBERON:0000073!7.58e-20!94;UBERON:0001016!7.58e-20!94;UBERON:0001017!1.11e-18!82;UBERON:0005743!1.22e-18!86;UBERON:0001869!2.07e-14!32;UBERON:0002020!2.45e-14!34;UBERON:0003528!2.45e-14!34;UBERON:0000955!4.44e-14!69;UBERON:0006238!4.44e-14!69;UBERON:0001049!6.38e-14!57;UBERON:0005068!6.38e-14!57;UBERON:0006241!6.38e-14!57;UBERON:0007135!6.38e-14!57;UBERON:0000956!7.49e-14!25;UBERON:0000203!7.49e-14!25;UBERON:0001893!7.81e-14!34;UBERON:0000924!1.01e-13!173;UBERON:0006601!1.01e-13!173;UBERON:0002619!2.39e-13!22;UBERON:0002346!2.44e-13!90;UBERON:0002780!2.49e-13!41;UBERON:0001890!2.49e-13!41;UBERON:0006240!2.49e-13!41;UBERON:0002791!2.97e-13!33;UBERON:0003080!2.28e-12!42;UBERON:0001950!3.08e-12!20;UBERON:0002616!3.39e-12!59;UBERON:0004121!4.31e-12!169;UBERON:0003075!2.09e-11!86;UBERON:0007284!2.09e-11!86;UBERON:0003056!2.99e-10!61;UBERON:0000064!1.14e-08!219;UBERON:0000153!7.58e-08!129;UBERON:0007811!7.58e-08!129;UBERON:0000033!2.99e-07!123;UBERON:0007023!6.71e-07!115
}}
}}

Revision as of 14:11, 21 May 2012


Full id: C145_neuroblastoma_peripheral_neuroectodermal_neuroepithelioma_carcinoid_adult_extraskeletal



Phase1 CAGE Peaks

Hg19::chr10:115469134..115469144,+p11@CASP7
Hg19::chr10:130493765..130493772,+p@chr10:130493765..130493772
+
Hg19::chr10:19206477..19206486,-p@chr10:19206477..19206486
-
Hg19::chr11:111061427..111061435,-p@chr11:111061427..111061435
-
Hg19::chr11:126898086..126898090,-p@chr11:126898086..126898090
-
Hg19::chr12:20097309..20097312,+p@chr12:20097309..20097312
+
Hg19::chr13:19866903..19866909,-p@chr13:19866903..19866909
-
Hg19::chr13:19866912..19866922,-p@chr13:19866912..19866922
-
Hg19::chr13:19867186..19867230,-p@chr13:19867186..19867230
-
Hg19::chr13:21817233..21817255,+p@chr13:21817233..21817255
+
Hg19::chr13:31573586..31573598,-p@chr13:31573586..31573598
-
Hg19::chr13:31576161..31576165,-p@chr13:31576161..31576165
-
Hg19::chr13:31586634..31586639,-p@chr13:31586634..31586639
-
Hg19::chr13:31590717..31590730,-p@chr13:31590717..31590730
-
Hg19::chr13:98503553..98503558,-p@chr13:98503553..98503558
-
Hg19::chr14:96944793..96944803,+p@chr14:96944793..96944803
+
Hg19::chr15:101818299..101818304,-p@chr15:101818299..101818304
-
Hg19::chr15:70867778..70867780,-p@chr15:70867778..70867780
-
Hg19::chr16:57880370..57880384,-p8@KIFC3
Hg19::chr16:8626896..8626903,+p@chr16:8626896..8626903
+
Hg19::chr16:8626925..8626935,+p@chr16:8626925..8626935
+
Hg19::chr16:8626942..8626951,+p@chr16:8626942..8626951
+
Hg19::chr16:8626961..8626972,+p@chr16:8626961..8626972
+
Hg19::chr16:8627043..8627056,+p@chr16:8627043..8627056
+
Hg19::chr16:8627138..8627146,+p@chr16:8627138..8627146
+
Hg19::chr18:3742467..3742480,-p19@DLGAP1
Hg19::chr18:56886837..56886844,+p@chr18:56886837..56886844
+
Hg19::chr18:56886851..56886854,+p@chr18:56886851..56886854
+
Hg19::chr18:56892776..56892782,+p6@GRP
Hg19::chr18:77044132..77044175,+p@chr18:77044132..77044175
+
Hg19::chr1:12710326..12710358,+p@chr1:12710326..12710358
+
Hg19::chr1:177701516..177701535,-p@chr1:177701516..177701535
-
Hg19::chr1:201328857..201328867,-p@chr1:201328857..201328867
-
Hg19::chr1:209796957..209796972,-p4@MIR4260
Hg19::chr1:209796983..209796993,-p6@MIR4260
Hg19::chr1:209797028..209797042,-p3@MIR4260
Hg19::chr1:209797044..209797052,-p7@MIR4260
Hg19::chr1:209797057..209797070,-p5@MIR4260
Hg19::chr1:209798010..209798013,-p@chr1:209798010..209798013
-
Hg19::chr1:209798058..209798063,-p@chr1:209798058..209798063
-
Hg19::chr1:236451669..236451673,+p@chr1:236451669..236451673
+
Hg19::chr1:236818586..236818597,+p@chr1:236818586..236818597
+
Hg19::chr1:247615972..247615977,-p@chr1:247615972..247615977
-
Hg19::chr1:39045718..39045723,-p@chr1:39045718..39045723
-
Hg19::chr1:60324644..60324660,+p@chr1:60324644..60324660
+
Hg19::chr1:72475310..72475318,+p@chr1:72475310..72475318
+
Hg19::chr20:24607850..24607857,-p@chr20:24607850..24607857
-
Hg19::chr20:24608066..24608086,-p@chr20:24608066..24608086
-
Hg19::chr20:24608551..24608564,-p@chr20:24608551..24608564
-
Hg19::chr20:24608570..24608595,-p@chr20:24608570..24608595
-
Hg19::chr20:24608639..24608641,-p@chr20:24608639..24608641
-
Hg19::chr20:49393105..49393130,+p@chr20:49393105..49393130
+
Hg19::chr21:27922896..27922913,+p@chr21:27922896..27922913
+
Hg19::chr21:27924233..27924255,+p@chr21:27924233..27924255
+
Hg19::chr21:27924313..27924341,+p@chr21:27924313..27924341
+
Hg19::chr21:27941000..27941004,+p@chr21:27941000..27941004
+
Hg19::chr21:28022135..28022171,+p@chr21:28022135..28022171
+
Hg19::chr21:28025780..28025786,+p@chr21:28025780..28025786
+
Hg19::chr21:28083005..28083006,+p@chr21:28083005..28083006
+
Hg19::chr21:46341022..46341041,+p2@ENST00000441379
p2@uc002zgh.2
Hg19::chr2:121797299..121797304,+p@chr2:121797299..121797304
+
Hg19::chr2:152185906..152185915,-p@chr2:152185906..152185915
-
Hg19::chr2:152185920..152185940,-p@chr2:152185920..152185940
-
Hg19::chr2:152185966..152185977,-p@chr2:152185966..152185977
-
Hg19::chr2:152186077..152186088,-p@chr2:152186077..152186088
-
Hg19::chr2:152186116..152186128,-p@chr2:152186116..152186128
-
Hg19::chr2:152186130..152186137,-p@chr2:152186130..152186137
-
Hg19::chr2:178013069..178013115,-p@chr2:178013069..178013115
-
Hg19::chr2:208528667..208528672,+p@chr2:208528667..208528672
+
Hg19::chr2:234265736..234265757,+p@chr2:234265736..234265757
+
Hg19::chr2:234265804..234265830,+p@chr2:234265804..234265830
+
Hg19::chr2:234699417..234699436,+p@chr2:234699417..234699436
+
Hg19::chr2:234699439..234699454,+p@chr2:234699439..234699454
+
Hg19::chr2:234699458..234699476,+p@chr2:234699458..234699476
+
Hg19::chr2:234699501..234699508,+p@chr2:234699501..234699508
+
Hg19::chr2:234699525..234699537,+p@chr2:234699525..234699537
+
Hg19::chr2:234699597..234699619,+p@chr2:234699597..234699619
+
Hg19::chr3:126191239..126191272,-p11@ZXDC
Hg19::chr3:197808599..197808629,-p@chr3:197808599..197808629
-
Hg19::chr3:197836976..197836989,+p1@ENST00000419104
p1@ENST00000422555
Hg19::chr3:58223326..58223335,+p5@ABHD6
Hg19::chr4:159766833..159766839,-p@chr4:159766833..159766839
-
Hg19::chr4:166503334..166503340,+p@chr4:166503334..166503340
+
Hg19::chr4:41750793..41750804,-p5@PHOX2B
Hg19::chr4:72897707..72897731,+p1@NPFFR2
Hg19::chr4:72897735..72897749,+p3@NPFFR2
Hg19::chr4:72897772..72897779,+p6@NPFFR2
Hg19::chr4:72897784..72897795,+p2@NPFFR2
Hg19::chr4:72897809..72897820,+p4@NPFFR2
Hg19::chr5:124007135..124007142,+p@chr5:124007135..124007142
+
Hg19::chr5:42970980..42970988,+p@chr5:42970980..42970988
+
Hg19::chr5:43033953..43033958,+p@chr5:43033953..43033958
+
Hg19::chr6:123160336..123160346,+p@chr6:123160336..123160346
+
Hg19::chr6:123160905..123160921,+p@chr6:123160905..123160921
+
Hg19::chr6:123160933..123160937,+p@chr6:123160933..123160937
+
Hg19::chr6:123194886..123194889,+p@chr6:123194886..123194889
+
Hg19::chr6:14537245..14537253,-p@chr6:14537245..14537253
-
Hg19::chr6:16804682..16804686,+p@chr6:16804682..16804686
+
Hg19::chr6:3939499..3939502,-p@chr6:3939499..3939502
-
Hg19::chr6:83931577..83931579,+p@chr6:83931577..83931579
+
Hg19::chr7:31232388..31232398,-p@chr7:31232388..31232398
-
Hg19::chr7:41976787..41976795,+p@chr7:41976787..41976795
+
Hg19::chr7:7553032..7553040,+p@chr7:7553032..7553040
+
Hg19::chr8:2072348..2072354,-p@chr8:2072348..2072354
-
Hg19::chr8:26723933..26723943,-p@chr8:26723933..26723943
-
Hg19::chr8:27041862..27041872,+p1@ENST00000521408
Hg19::chr8:28174496..28174516,+p3@PNOC
Hg19::chr8:28200458..28200480,+p@chr8:28200458..28200480
+
Hg19::chr8:37560262..37560269,-p@chr8:37560262..37560269
-
Hg19::chr8:70745541..70745555,-p3@SLCO5A1
Hg19::chr8:97136855..97136857,-p@chr8:97136855..97136857
-
Hg19::chr8:97173993..97174018,-p@chr8:97173993..97174018
-
Hg19::chr8:97174234..97174264,-p@chr8:97174234..97174264
-
Hg19::chr8:97178060..97178066,+p@chr8:97178060..97178066
+
Hg19::chr9:90112117..90112164,+p19@DAPK1
Hg19::chrX:135918268..135918276,+p@chrX:135918268..135918276
+
Hg19::chrX:25034686..25034690,-p@chrX:25034686..25034690
-
Hg19::chrX:2712069..2712080,+p6@XG


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0005184neuropeptide hormone activity0.0115249039428662



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br>disease_data<br>

Uber Anatomy
Ontology termp-valuen
regional part of nervous system7.58e-2094
nervous system7.58e-2094
central nervous system1.11e-1882
cerebral hemisphere2.07e-1432
gray matter2.45e-1434
brain grey matter2.45e-1434
brain4.44e-1469
future brain4.44e-1469
neural tube6.38e-1457
neural rod6.38e-1457
future spinal cord6.38e-1457
neural keel6.38e-1457
cerebral cortex7.49e-1425
pallium7.49e-1425
telencephalon7.81e-1434
ectoderm1.01e-13173
presumptive ectoderm1.01e-13173
regional part of cerebral cortex2.39e-1322
neurectoderm2.44e-1390
regional part of forebrain2.49e-1341
forebrain2.49e-1341
future forebrain2.49e-1341
regional part of telencephalon2.97e-1333
anterior neural tube2.28e-1242
neocortex3.08e-1220
regional part of brain3.39e-1259
ectoderm-derived structure4.31e-12169
neural plate2.09e-1186
presumptive neural plate2.09e-1186
pre-chordal neural plate2.99e-1061
organ part1.14e-08219
anterior region of body7.58e-08129
craniocervical region7.58e-08129
head2.99e-07123
adult organism6.71e-07115
Disease
Ontology termp-valuen
germ cell and embryonal cancer6.85e-0922
germ cell cancer6.85e-0922
cancer5.19e-07235
cell type cancer8.04e-07143


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=Coexpression_cluster:C145&oldid=1704094"